CB Insights
Technology Market Intelligence
Technology Market Intelligence
Public list: Pharma Startups (6570)
RedHill Biopharma (NASDAQ: RDHL) (Tel-Aviv Stock Exchange: RDHL) is an Israeli pharmaceutical company focused primarily on acquisition and development of late clinical-stage new formulations of existing drugs.
Company (IPO / Went public)
Phone: +972-(0)3-541-3131
21 Ha’arba’a St.
Tel Aviv, 6473921
Israel
| Per Week | Per Month | Per 6 Months | Per Year | |
|---|---|---|---|---|
| Rank | Login to see details | |||
| Page Views Per Million | Login to see details | |||
| Page Views Per User | Login to see details | |||
| Reach Per Million | Login to see details | |||
| Investor | Investor Type | Location | Participating Rounds |
|---|
| Title | Application Date | Patent Date | Status (Patent / Application) |
|---|---|---|---|
| Therapy for inhibition of single-stranded rna virus replication | Oct 23, 2015 | May 22, 2018 | Patent |
| Composition and method for treating an autoimmune disease | Sep 19, 2012 | Feb 27, 2018 | Patent |
| Combination therapies for treating cancer | Oct 06, 2016 | Dec 19, 2017 | Patent |
| Ondansetron extended release solid dosage forms for treating either nausea, vomiting or diarrhea symptoms | Mar 11, 2015 | Jun 13, 2017 | Patent |
| Antiemetic extended release solid dosage forms | Mar 14, 2014 | May 02, 2017 | Patent |
